Indication and Safety Information
Thermi’s temperature-controlled RF system, ARVATI, is indicated:
For use in dermatological and general surgical procedures for electrocoagulation and hemostasis. To create lesions in nervous tissue.
Important Safety Considerations:
Thermi® radiofrequency products should not be used on patients who are pregnant, have a fever or skin infection in or around the area of application. Expected procedure side effects may include transient pain in procedure area, erythema and edema.